🇺🇸 FDA
Patent

US 8512964

Targets for treatment of hypercholesterolemia

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 8512964 (Targets for treatment of hypercholesterolemia) held by The Regents of the University of California expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/7105, A61K31/713, A61K39/3955, A61P